603676 卫信康
已收盘 07-07 15:00:00
资讯
新帖
简况
卫信康（603676）披露2025年年度权益分派实施公告，6月22日股价下跌0.69%
证券之星 · 06-22
卫信康（603676）披露2025年年度权益分派实施公告，6月22日股价下跌0.69%
每周股票复盘：卫信康（603676）拟出资1500万参投医疗健康基金
证券之星 · 05-31
每周股票复盘：卫信康（603676）拟出资1500万参投医疗健康基金
卫信康（603676）披露参与认购私募基金份额公告，5月27日股价下跌1.6%
证券之星 · 05-27
卫信康（603676）披露参与认购私募基金份额公告，5月27日股价下跌1.6%
每周股票复盘：卫信康（603676）2025年年度股东会审议通过利润分配等11项议案
证券之星 · 05-17
每周股票复盘：卫信康（603676）2025年年度股东会审议通过利润分配等11项议案
卫信康（603676）披露2025年年度股东会决议公告，5月14日股价下跌1.46%
证券之星 · 05-14
卫信康（603676）披露2025年年度股东会决议公告，5月14日股价下跌1.46%
股市必读：卫信康（603676）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：卫信康（603676）5月8日披露最新机构调研信息
每周股票复盘：卫信康（603676）2025年现金分红总额141,373,479.60元
证券之星 · 05-10
每周股票复盘：卫信康（603676）2025年现金分红总额141,373,479.60元
股市必读：卫信康年报 - 第四季度单季净利润同比增长371.15%
证券之星 · 04-27
股市必读：卫信康年报 - 第四季度单季净利润同比增长371.15%
每周股票复盘：卫信康（603676）一季度净利降19.16%
证券之星 · 04-26
每周股票复盘：卫信康（603676）一季度净利降19.16%
卫信康(603676.SH)发布一季度业绩，归母净利润6834万元，同比下降19.16%
智通财经 · 04-23
卫信康(603676.SH)发布一季度业绩，归母净利润6834万元，同比下降19.16%
股市必读：卫信康（603676）3月23日收盘跌6.54%，主力净流出149.55万元
证券之星 · 03-24
股市必读：卫信康（603676）3月23日收盘跌6.54%，主力净流出149.55万元
突发涨价潮！维生素价格跳涨超35%，盈利拐点真的来了？
中金财经 · 03-19
突发涨价潮！维生素价格跳涨超35%，盈利拐点真的来了？
每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证
证券之星 · 03-08
每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证
卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书
智通财经 · 03-06
卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书
卫信康03月10日获主力加仓173万元
市场透视 · 2025-03-10
卫信康03月10日获主力加仓173万元
卫信康03月04日遭主力抛售34万元
市场透视 · 2025-03-04
卫信康03月04日遭主力抛售34万元
卫信康：注射用多种维生素（12）在河北、江苏集采中中选
金融界 · 2025-02-28
卫信康：注射用多种维生素（12）在河北、江苏集采中中选
卫信康：产品“复方氨基酸注射液”取得注册证
每日经济新闻 · 2025-02-25
卫信康：产品“复方氨基酸注射液”取得注册证
卫信康(603676.SH)获得复方氨基酸注射液(18AA-Ⅶ)药品注册证书
智通财经 · 2025-02-25
卫信康(603676.SH)获得复方氨基酸注射液(18AA-Ⅶ)药品注册证书
加载更多
公司概况
公司名称：
西藏卫信康医药股份有限公司
所属行业：
医药制造业
上市日期：
2017-07-21
主营业务：
西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素、多种微量元素注射液、小儿多种维生素注射液、复方氨基酸注射液、吸入用乙酰半胱氨酸溶液、复方电解质注射液、混合糖电解质注射液、门冬氨酸钾注射液、蔗糖铁注射液。
发行价格：
5.53
{"stockData":{"symbol":"603676","market":"SH","secType":"STK","nameCN":"卫信康","latestPrice":8.81,"timestamp":1783407601000,"preClose":9.01,"halted":0,"volume":2797667,"delay":0,"changeRate":-0.0222,"floatShares":434999999,"shares":434999999,"eps":0.4979,"marketStatus":"已收盘","change":-0.2,"latestTime":"07-07 15:00:00","open":9.02,"high":9.02,"low":8.81,"amount":24895700,"amplitude":0.0233,"askPrice":8.82,"askSize":20,"bidPrice":8.81,"bidSize":174,"shortable":0,"etf":0,"ttmEps":0.4979,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783474200000},"marketStatusCode":5,"adr":0,"adjPreClose":9.01,"symbolType":"stock","openAndCloseTimeList":[[1783387800000,1783395000000],[1783400400000,1783407600000]],"highLimit":9.91,"lowLimit":8.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":435161500,"isCdr":false,"pbRate":2.48,"roa":"--","peRate":17.694316,"roe":"4.52%","epsLYR":0.54,"committee":0.493976,"marketValue":3834000000,"turnoverRate":0.0064,"status":1,"floatMarketCap":3834000000},"requestUrl":"/m/hq/s/603676","defaultTab":"news","newsList":[{"id":"2645075354","title":"卫信康（603676）披露2025年年度权益分派实施公告，6月22日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645075354","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645075354?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:58","pubTimestamp":1782140296,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，卫信康报收于8.58元，较前一交易日下跌0.69%，最新总市值为37.34亿元。该股当日开盘8.64元，最高8.71元，最低8.27元，成交额达2015.43万元，换手率为0.55%。近日，西藏卫信康医药股份有限公司发布《2025年年度权益分派实施公告》：每股现金红利0.18元（含税），股权登记日为2026年6月26日，除权（息）日和现金红利发放日均为2026年6月29日。根据持股期限不同，自然人股东股息红利所得税实行差别化税率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639602876","title":"每周股票复盘：卫信康（603676）拟出资1500万参投医疗健康基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2639602876","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639602876?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:41","pubTimestamp":1780173669,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，卫信康报收于9.23元，较上周的9.66元下跌4.45%。本周，卫信康5月25日盘中最高价报9.73元。卫信康当前最新总市值40.17亿元，在化学制药板块市值排名107/150，在两市A股市值排名3845/5207。本周关注点公司公告汇总：卫信康拟出资1,500万元认购安徽华盖尔臻股权投资基金份额，占比5.29%。基金管理人为华盖资本有限责任公司，公司作为有限合伙人以出资额为限承担责任，无保本及最低收益承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0239","159760","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638689010","title":"卫信康（603676）披露参与认购私募基金份额公告，5月27日股价下跌1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638689010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638689010?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:44","pubTimestamp":1779893058,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，卫信康报收于9.2元，较前一交易日下跌1.6%，最新总市值为40.03亿元。近日，西藏卫信康医药股份有限公司发布《参与认购私募基金份额的公告》。公告显示，公司拟作为有限合伙人出资1,500万元认购安徽华盖尔臻股权投资基金合伙企业份额，占基金已募集总额的5.29%。基金管理人为华盖资本有限责任公司，公司作为有限合伙人以出资额为限承担责任，无保本及最低收益承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603676","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636306266","title":"每周股票复盘：卫信康（603676）2025年年度股东会审议通过利润分配等11项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2636306266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636306266?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:17","pubTimestamp":1778962630,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，卫信康报收于10.06元，较上周的10.51元下跌4.28%。本周，卫信康5月11日盘中最高价报10.7元。本周关注点公司公告汇总：卫信康2025年年度股东会审议通过2025年度利润分配方案等11项议案。公司公告汇总西藏卫信康医药股份有限公司于2026年5月14日召开2025年年度股东会，会议由董事会召集，董事长张勇主持，采用现场与网络投票结合方式召开。出席会议股东共207人，代表有表决权股份276,474,955股，占公司总股本的63.9493%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635465897","title":"卫信康（603676）披露2025年年度股东会决议公告，5月14日股价下跌1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635465897","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635465897?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:42","pubTimestamp":1778769737,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，卫信康报收于10.15元，较前一交易日下跌1.46%，最新总市值为44.17亿元。该股当日开盘10.27元，最高10.29元，最低10.15元，成交额达1608.93万元，换手率为0.36%。近日，西藏卫信康医药股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月14日召开2025年年度股东会，出席会议股东共207人，代表有表决权股份276,474,955股，占公司总股本的63.9493%。其中议案6和议案10为特别决议议案，获出席股东所持表决权三分之二以上通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634742996","title":"股市必读：卫信康（603676）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634742996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634742996?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:04","pubTimestamp":1778443456,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，卫信康报收于10.51元，上涨0.48%，换手率0.34%，成交量1.48万手，成交额1551.43万元。交易信息汇总资金流向5月8日主力资金净流出97.8万元，占总成交额6.3%；游资资金净流出47.61万元，占总成交额3.07%；散户资金净流入145.41万元，占总成交额9.37%。2025年度现金分红总额为141,373,479.60元，占归母净利润的60.71%。董事会提请股东大会授权其在符合条件时制定2026年中期利润分配方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634441216","title":"每周股票复盘：卫信康（603676）2025年现金分红总额141,373,479.60元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634441216","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634441216?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:38","pubTimestamp":1778355491,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，卫信康报收于10.51元，较上周的10.6元下跌0.85%。本周，卫信康5月6日盘中最高价报10.74元。卫信康当前最新总市值45.74亿元，在化学制药板块市值排名106/150，在两市A股市值排名3764/5200。来自机构调研要点：公司将以临床需求为导向，向围手术期及儿科用药方向发展。2025年度现金分红总额141,373,479.60元，占本年度归属于上市公司股东净利润的60.71%。董事会提请股东会授权董事会在满足条件的前提下制定2026年中期利润分配方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630358589","title":"股市必读：卫信康年报 - 第四季度单季净利润同比增长371.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630358589","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630358589?lang=zh_cn&edition=full","pubTime":"2026-04-27 09:29","pubTimestamp":1777253362,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，卫信康报收于10.38元，上涨1.76%，换手率0.71%，成交量3.09万手，成交额3194.51万元。来自：卫信康2025年归母净利润2.33亿元，同比下降5.41%；但第四季度归母净利润同比上升371.15%。股本股东变化股东户数变动近日卫信康披露，截至2026年3月31日公司股东户数为1.57万户，较12月31日增加100.0户，增幅为0.64%。分红金额上限为当期归属于上市公司股东净利润的100%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700009262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807090","title":"每周股票复盘：卫信康（603676）一季度净利降19.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807090?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:31","pubTimestamp":1777156264,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，卫信康报收于10.38元，较上周的10.25元上涨1.27%。本周，卫信康4月20日盘中最高价报10.45元。业绩披露要点卫信康2026年一季报显示，公司主营收入3.22亿元，同比增长8.9%；归母净利润6833.93万元，同比下降19.16%；扣非净利润6794.85万元，同比下降8.61%；负债率20.83%，投资收益269.35万元，财务费用-15.23万元，毛利率60.19%。本年度现金分红总额141,373,479.60元，现金分红和股份回购金额合计占归属于上市公司股东净利润的60.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629883206","title":"卫信康(603676.SH)发布一季度业绩，归母净利润6834万元，同比下降19.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629883206","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629883206?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:11","pubTimestamp":1776949862,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)披露2026年第一季度报告，报告期公司实现营收3.22亿元，同比增长8.90%;归母净利润6834万元，同比下降19.16%;扣非净利润6795万元，同比下降8.61%。基本每股收益0.16元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621015084","title":"股市必读：卫信康（603676）3月23日收盘跌6.54%，主力净流出149.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621015084","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621015084?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:31","pubTimestamp":1774297870,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，卫信康报收于9.72元，下跌6.54%，换手率0.79%，成交量3.43万手，成交额3394.06万元。当日关注点来自交易信息汇总：卫信康股价3月23日收跌6.54%，报9.72元，已连续3日下跌。来自资金流向：主力资金3月23日净流出149.55万元，占总成交额4.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603676","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620246290","title":"突发涨价潮！维生素价格跳涨超35%，盈利拐点真的来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2620246290","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620246290?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:00","pubTimestamp":1773914401,"startTime":"0","endTime":"0","summary":"核心品种价格持续走高从具体品类来看，维生素A、维生素E成为本轮涨价的核心品种，涨幅明显且传导迅速。在成本端上游化工原料涨价，以及油运价格上涨等因素刺激下，业内控产涨价意愿强烈。机构扎堆调研维生素价格上涨快速传导至资本市场，产业链上市公司成为机构关注的重点标的，调研次数大幅增加。维生素品类价格自去年第四季度以来已实现企稳回升。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/19/20260319780631.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/19/20260319780631.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260319/32081868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0191","BK0201","LU0405327148.USD","BK0197","002626","603079","BK0226","BK0239","BK0188","603676","BK0077","BK0187","BK0070","BK0186","LU0405327494.USD","002562","002001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617636246","title":"每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617636246","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617636246?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:14","pubTimestamp":1772910853,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，卫信康报收于10.91元，较上周的11.23元下跌2.85%。本周，卫信康3月2日盘中最高价报11.22元。本周关注点来自公司公告汇总：子公司获注射用硫酸艾沙康唑药品注册证书，视同通过一致性评价。公司公告汇总西藏卫信康医药股份有限公司全资子公司内蒙古白医制药股份有限公司近日收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑《药品注册证书》，批准注册并视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617686498","title":"卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2617686498","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617686498?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:37","pubTimestamp":1772789822,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)发布公告，近日，公司全资子公司内蒙古白医制药股份有限公司(简称“白医制药”)收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑《药品注册证书》。注射用硫酸艾沙康唑适用于治疗成人患者下列感染：侵袭性曲霉病，侵袭性毛霉病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603676","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518901552","title":"卫信康03月10日获主力加仓173万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518901552","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518901552?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:21","pubTimestamp":1741591263,"startTime":"0","endTime":"0","summary":"03月10日, 卫信康股价涨2.72%，报收9.83元，成交金额3576万元，换手率0.84%，振幅3.13%，量比1.47。卫信康今日主力资金净流入173万元，上一交易日主力净流入174万元。|03月10日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|华丰股份|6.05%|#|中科云网|4.14%|#|黄河旋风|4.03%|#|泰尔股份|3.98%|#|塞力医疗|3.96%|#|东方锆业|3.83%|#|海立股份|3.57%|#|创业慧康|3.57%|#|威派格|3.49%|#|博济医药|3.48%|卫信康所在的化学制药行业，今日主力净流出6186万元，行业排名55/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310161951abf27fc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310161951abf27fc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0191","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516644169","title":"卫信康03月04日遭主力抛售34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516644169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516644169?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:21","pubTimestamp":1741072862,"startTime":"0","endTime":"0","summary":"03月04日, 卫信康股价跌0.73%，报收9.53元，成交金额2369万元，换手率0.57%，振幅1.46%，量比0.93。卫信康今日主力资金净流出34万元，上一交易日主力净流出219万元。|03月04日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N常友科技|31.45%|#|N汇通|19.85%|#|赛为智能|9.60%|#|北方长龙|7.84%|#|信邦智能|6.61%|#|好上好|6.38%|#|南方精工|5.45%|#|创业慧康|5.14%|#|城地香江|4.48%|#|立航科技|4.32%|卫信康所在的化学制药行业，今日主力净流出6.19亿元，行业排名7/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304162121a25e863c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304162121a25e863c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603676","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376312","title":"卫信康：注射用多种维生素（12）在河北、江苏集采中中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376312","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376312?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:06","pubTimestamp":1740730015,"startTime":"0","endTime":"0","summary":"金融界2月28日消息， 卫信康披露投资者关系活动记录表显示，公司注射用多种维生素（12）在河南十九省联盟集中带量采购、浙江第四批药品集中带量采购中中选，截止2024年末，共有20个省（区、兵团）正式执行中选结果。2025年1月，注射用多种维生素（12）在河北牵头的京津冀赣化学药品集中带量采购、江苏省第五轮药品集中带量采购中中选。公司多种微量元素注射液在京津冀“3+N”联盟集中带量采购中中选，截止2024年末，共有11个省（区、兵团）正式执行中选结果。2025年1月，江苏省第五轮药品集采拟中选结果公布，多种微量元素注射液、多种微量元素注射液(I) 拟中选。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281609279633aac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281609279633aac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0191","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514205127","title":"卫信康：产品“复方氨基酸注射液”取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2514205127","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514205127?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:52","pubTimestamp":1740469964,"startTime":"0","endTime":"0","summary":"每经AI快讯，卫信康 2月25日晚间发布公告称，近日，西藏卫信康医药股份有限公司全资子公司内蒙古白医制药股份有限公司收到国家药品监督管理局核准签发的复方氨基酸注射液《药品注册证书》。产品名称为“复方氨基酸注射液”。2023年1至12月份，卫信康的营业收入构成为：医药制造业占比99.97%。卫信康的总经理、董事长均是张勇，男，52岁，学历背景为硕士。截至发稿，卫信康市值为41亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225155323962f86af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225155323962f86af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603676","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514505689","title":"卫信康(603676.SH)获得复方氨基酸注射液(18AA-Ⅶ)药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514505689","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514505689?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:32","pubTimestamp":1740468765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)公告，近日，公司全资子公司内蒙古白医制药股份有限公司(简称“白医制药”)收到国家药品监督管理局(简称“国家药监局”)核准签发的复方氨基酸注射液(18AA-Ⅶ)《药品注册证书》。复方氨基酸注射液(18AA-Ⅶ)为成人氨基酸补充剂，用于低蛋白血症、低营养状态和手术前后的氨基酸补充。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0191","BK0239","603676"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783415934911,"stockEarnings":[{"period":"1week","weight":0.0816},{"period":"1month","weight":0.0256},{"period":"3month","weight":-0.1472},{"period":"6month","weight":-0.1687},{"period":"1year","weight":-0.2642},{"period":"ytd","weight":-0.1246}],"compareEarnings":[{"period":"1week","weight":-0.008},{"period":"1month","weight":0.0034},{"period":"3month","weight":0.0388},{"period":"6month","weight":-0.0109},{"period":"1year","weight":0.1638},{"period":"ytd","weight":0.0182}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏卫信康医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15688人(较上一季度增加0.64%)","perCapita":"27738股","listingDate":"2017-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区B区园区南路5号工业中心4号楼3层","registeredCapital":"43516万元","survey":" 西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素、多种微量元素注射液、小儿多种维生素注射液、复方氨基酸注射液、吸入用乙酰半胱氨酸溶液、复方电解质注射液、混合糖电解质注射液、门冬氨酸钾注射液、蔗糖铁注射液。","listedPrice":5.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卫信康,603676,卫信康股票,卫信康股票老虎,卫信康股票老虎国际,卫信康行情,卫信康股票行情,卫信康股价,卫信康股市,卫信康股票价格,卫信康股票交易,卫信康股票购买,卫信康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}